IP Library Patent Application 15173170
Patent Application
App. No. 15/173,170

METHODS FOR DETECTING ALLOSTERIC MODULATORS OF PROTEIN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/173,170
Abstract

The present invention discloses, inter alia, methods for labeling a target protein with an SHG-active probe for detection by second harmonic or sum-frequency generation in order to identify agents which bind to an allosteric site on the target protein thereby altering its structural conformation

Claims (23)

1 - 79 . (canceled)

80 . An apparatus for detection of target protein-allosteric modulator binding interactions, the apparatus comprising:

a) one or more light sources configured to provide light of one or more fundamental frequencies;

b) a substrate comprising a functionalized surface for attachment of a target protein labeled with a nonlinear-active moiety, wherein the surface-attached target protein has a net orientation at the surface, and wherein the substrate is configured so that surface-attached target protein is illuminated by light of the one or more fundamental frequencies, thereby generating light of a higher order frequency; and

c) a detector for measuring a property of the higher order frequency light, or changes thereof, upon contacting the surface-attached target protein with a ligand known to bind to an active site of the target protein, and (i) an allosteric modulator of the target protein, or (ii) a candidate allosteric modulator of the target protein.

81 . The apparatus of claim 80 , wherein the one or more light sources are one or more lasers.

82 . The apparatus of claim 80 , wherein the substrate is made of silica, glass, silicon, polystyrene, polycarbonate, nylon, a plastic, a metal, a semiconductor, or an insulator.

83 . The apparatus of claim 80 , wherein the functionalized surface comprises a supported phospholipid bilayer.

84 . The apparatus of claim 80 , wherein the detector is a photomultiplier tube (PMT), photodiode, avalanche photodiode, or CCD detector.

85 . The apparatus of claim 80 , further comprising a monochromator for selection of the fundamental light frequency or higher order light frequency.

86 . The apparatus of claim 80 , further comprising a bandpass filter, color filter, or interference filter to separate light of the fundamental frequency from light of the higher order frequency.

87 . The apparatus of claim 80 , further comprising one or more polarizing optics.

88 . The apparatus of claim 80 , further comprising a computer and software for controlling the illumination of the surface-attached target protein in step (b) and measuring a property of the higher order frequency light, or changes thereof, in step (c) upon contacting the surface-attached target protein with a ligand known to bind to an active site of the target protein, and (i) an allosteric modulator of the target protein, or (ii) a candidate allosteric modulator of the target protein.

89 . The apparatus of claim 80 , wherein the target protein is selected from the group consisting of a G protein-coupled receptor, a steroid hormone receptor, or a tyrosine kinase receptor.

90 . The apparatus of claim 80 , wherein the nonlinear active moiety is selected from the group consisting of PyMPO maleimide, PyMPO-NHS, PyMPO-succinimidyl ester, Badan, Acrylodan, and an unnatural amino acid.

91 . The apparatus of claim 80 , wherein the surface-attached target protein is illuminated by the light of the one or more fundamental frequencies using a surface-selective technique.

92 . The apparatus of claim 81 , wherein the surface selective technique comprises the use of total internal reflection.

93 . The apparatus of claim 80 , wherein the light of a higher order frequency is second harmonic, sum frequency, or difference frequency light.

94 . The apparatus of claim 80 , wherein the property of the higher order frequency light to be measured is intensity, wavelength, or polarization.

95 . The apparatus of claim 80 , wherein the ligand is a protein, a nucleic acid, a phospholipid, a carbohydrate, a small molecule, or a co-factor.

96 . The apparatus of claim 80 , wherein the allosteric modulator or candidate allosteric modulator is a small molecule, an antibody, a non-antibody polypeptide, a carbohydrate, or an inhibitory nucleic acid.

97 . The apparatus of claim 80 , wherein the property of the higher order frequency light, or changes thereof, are measured in real-time upon contacting the surface-attached target protein with a ligand known to bind to an active site of the target protein, an allosteric modulator of the target protein, a candidate allosteric modulator of the target protein, or any combination thereof.

98 . The apparatus of claim 80 , wherein the nonlinear-active moiety is a second harmonic-active moiety, and wherein the light of a higher order frequency is verified as second harmonic light by determining its quadratic dependence on the intensity of the fundamental light.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: BLUELIGHT THERAPEUTICS, INC.
To: QUANTA THERAPEUTICS, INC.
Reel/Frame 057721/0206 →
CHANGE OF NAME Recorded Jun 24, 2020
From: BIODESY, INC.
To: BLUELIGHT THERAPEUTICS, INC.
Reel/Frame 053834/0130 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2016
From: SALAFSKY, JOSHUA S.
To: BIODESY, INC.
Reel/Frame 039131/0483 →